President of Lebanon’s Women Leaders Council: We Refuse to Surrender to the Status Quo

President of Lebanon’s Women Leaders Council: We Refuse to Surrender to the Status Quo
TT

President of Lebanon’s Women Leaders Council: We Refuse to Surrender to the Status Quo

President of Lebanon’s Women Leaders Council: We Refuse to Surrender to the Status Quo

Despite all the difficult economic conditions afflicting Lebanon, Madiha Raslan, president and founder of the Lebanese Council for Women Leaders, insists on moving forward with her mission without losing hope.

Since 2018, Raslan began her official career within economic organizations through establishing and chairing the Lebanese Council for Women Leaders, after assuming the position of Vice President of the Lebanese Association for Franchise Licenses in 2009, following more than 19 years of experience in the business field.

In an interview with Asharq Al-Awsat, Raslan talks about her experience in the Council, which she established with the support of Prime Minister-designate Saad Hariri and the head of economic bodies in Lebanon, Mohammad Shukair. She describes the step as a “challenge”, which she succeeded in overcoming before it collided with the economic and political crisis that hit Lebanon since 2019.

Upon its formation, the Council gathered about 12 businesswomen from various sectors until the number reached 120 currently. The main goal is to integrate Lebanese women into the economic system and enable them to become partners in decision making.

In this regard, she says that the foundations to achieve this goal were present, but collided with the political crisis in Lebanon, which is badly affecting the economy.

“In Lebanon, the greatest challenge is the political situation, meaning that political stability is the basis that would constitute the solution, or at least open a door for a solution,” she tells Asharq Al-Awsat.

She continues: “As a private sector, we do not ask officials and politicians for money or anything. We just want them to think of Lebanon as a country for our children… instead of taking it hostage to non-Lebanese interests…”

Raslan, however, refuses to talk about accepting the status quo. In response to a question about whether she feels hopeless, she says: “There is no doubt that the whole country is in a state of despair, but hope is always there, which makes us resist, continue to search for solutions and make efforts to save the situation.”

She reveals that the Council is working on a recovery plan by seeking to bring fresh dollars into the market to activate the economic wheel, which could be achieved through expatriates who have confidence in the private sector or with investments in Lebanese companies.

Raslan affirms that Lebanese women will have a major role in the future of their country, reiterating that providing specific foundations and factors will help revive the economic sector.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.